MC2149A1 - Interferons leucocytaires stabilises - Google Patents

Interferons leucocytaires stabilises

Info

Publication number
MC2149A1
MC2149A1 MC902149A MC2149A MC2149A1 MC 2149 A1 MC2149 A1 MC 2149A1 MC 902149 A MC902149 A MC 902149A MC 2149 A MC2149 A MC 2149A MC 2149 A1 MC2149 A1 MC 2149A1
Authority
MC
Monaco
Prior art keywords
leukocytais
interfer
stabilized
stabilized leukocytais
Prior art date
Application number
MC902149A
Other languages
English (en)
Inventor
Ferro Alberto
Original Assignee
Hoffmann La Roche
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoffmann La Roche filed Critical Hoffmann La Roche
Publication of MC2149A1 publication Critical patent/MC2149A1/fr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/19—Cytokines; Lymphokines; Interferons
    • A61K38/21—Interferons [IFN]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/28—Steroids, e.g. cholesterol, bile acids or glycyrrhetinic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/19—Cytokines; Lymphokines; Interferons
    • A61K38/21—Interferons [IFN]
    • A61K38/212—IFN-alpha
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/19—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles lyophilised, i.e. freeze-dried, solutions or dispersions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Immunology (AREA)
  • Zoology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Communicable Diseases (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Virology (AREA)
  • Oncology (AREA)
  • Dermatology (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
MC902149A 1989-09-28 1990-09-24 Interferons leucocytaires stabilises MC2149A1 (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CH351489 1989-09-28

Publications (1)

Publication Number Publication Date
MC2149A1 true MC2149A1 (fr) 1992-03-10

Family

ID=4257630

Family Applications (1)

Application Number Title Priority Date Filing Date
MC902149A MC2149A1 (fr) 1989-09-28 1990-09-24 Interferons leucocytaires stabilises

Country Status (26)

Country Link
EP (1) EP0420049B1 (fr)
JP (1) JPH03130232A (fr)
KR (1) KR910005886A (fr)
CN (1) CN1050503A (fr)
AR (1) AR244551A1 (fr)
AT (1) ATE92334T1 (fr)
AU (1) AU636653B2 (fr)
CA (1) CA2024046A1 (fr)
CZ (1) CZ277712B6 (fr)
DD (1) DD298054A5 (fr)
DE (1) DE59002183D1 (fr)
FI (1) FI904756A0 (fr)
HU (1) HU205555B (fr)
IE (1) IE903479A1 (fr)
IL (1) IL95769A0 (fr)
IS (1) IS3631A7 (fr)
MC (1) MC2149A1 (fr)
MX (1) MX22522A (fr)
MY (1) MY106615A (fr)
NO (1) NO904218L (fr)
NZ (1) NZ235153A (fr)
PH (1) PH27531A (fr)
PT (1) PT95454A (fr)
RU (1) RU2008017C1 (fr)
YU (1) YU184090A (fr)
ZA (1) ZA907579B (fr)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1994028020A1 (fr) * 1993-05-18 1994-12-08 Bukh Meditec A/S Procede de preparation d'interferons
ATE224725T1 (de) * 1996-05-09 2002-10-15 Feronpatent Ltd Stabilisierung von interferonen in wässriger lösung durch gummiarabikum
EP1007083A1 (fr) * 1997-05-09 2000-06-14 Feronpatent Limited Stabilisation d'interferons dans une solution aqueuse en vue de la fabrication de pastilles que l'on administre par voie sublinguale
ID28470A (id) * 1998-03-26 2001-05-24 Schering Corp Formulasi-formulasi untuk perlindungan terhadap konjugasi polietilen glikol-interferon alfa
US6180096B1 (en) 1998-03-26 2001-01-30 Schering Corporation Formulations for protection of peg-interferon alpha conjugates
CN1175901C (zh) * 1999-12-06 2004-11-17 天津华立达生物工程有限公司 一种稳定的干扰素水溶液
MX2007001663A (es) 2004-08-12 2007-04-10 Schering Corp Formulacion de interferon pegilado estable.
DE102004048379A1 (de) 2004-10-01 2006-04-13 "Stiftung Caesar" (Center Of Advanced European Studies And Research) Federelement aus gesputterter Formgedächtnis-Legierung
CU23432B6 (es) * 2005-11-02 2009-10-16 Ct Ingenieria Genetica Biotech Formulaciones estabilizadas que contienen a los interferones gamma y alfa en proporciones potenciadoras

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5821691A (ja) * 1981-07-29 1983-02-08 Mochida Pharmaceut Co Ltd α−及びβ−インタ−フェロンの精製方法
DE3273597D1 (en) * 1981-11-28 1986-11-06 Sunstar Kk Pharmaceutical composition containing interferon in stable state
ATE31023T1 (de) * 1983-04-28 1987-12-15 Armour Pharma Pharmazeutische zubereitung mit gehalt an gereinigtem fibrinonectin.
DE3484374D1 (de) * 1983-08-04 1991-05-08 Green Cross Corp Gamma-interferonzusammensetzung.
NO861139L (no) * 1985-03-25 1986-09-26 Schering Corp Stabilt gamma-interferonpreparat.
US4816568A (en) * 1986-05-16 1989-03-28 International Minerals & Chemical Corp. Stabilization of growth hormones

Also Published As

Publication number Publication date
DE59002183D1 (de) 1993-09-09
JPH03130232A (ja) 1991-06-04
DD298054A5 (de) 1992-02-06
MY106615A (en) 1995-06-30
EP0420049A1 (fr) 1991-04-03
NZ235153A (en) 1993-03-26
HU205555B (en) 1992-05-28
KR910005886A (ko) 1991-04-27
IL95769A0 (en) 1991-06-30
CS432890A3 (en) 1992-12-16
IE903479A1 (en) 1991-04-10
HU906021D0 (en) 1991-03-28
AU6309890A (en) 1991-04-11
CA2024046A1 (fr) 1991-03-29
FI904756A0 (fi) 1990-09-27
AU636653B2 (en) 1993-05-06
AR244551A1 (es) 1993-11-30
ATE92334T1 (de) 1993-08-15
PT95454A (pt) 1991-05-22
CN1050503A (zh) 1991-04-10
HUT56284A (en) 1991-08-28
ZA907579B (en) 1991-06-26
NO904218D0 (no) 1990-09-27
CZ277712B6 (en) 1993-03-17
MX22522A (es) 1993-10-01
NO904218L (no) 1991-04-02
YU184090A (sh) 1992-09-07
RU2008017C1 (ru) 1994-02-28
IS3631A7 (is) 1991-03-29
PH27531A (en) 1993-08-18
EP0420049B1 (fr) 1993-08-04

Similar Documents

Publication Publication Date Title
DK0396968T3 (da) Mejetærsker
FR2632154B1 (fr) Moissonneuse
KR900006738A (ko) 전자렌지
DK348289D0 (da) Forbindelser
ATA247090A (de) Klemmanordnung
BR9001646A (pt) Ziper ornamental
NO914160D0 (no) Stabilisert vismutoksid
BR8906323A (pt) Conjunto compressor
DE69029227D1 (de) Gleitbauteil
MC2149A1 (fr) Interferons leucocytaires stabilises
DE59107890D1 (de) Etagenbackofen
FR2645561B3 (fr) Structure extensible
DK0400327T3 (da) Mejetærsker
FR2632837B1 (fr) Etagere-bibliotheque extensible
DK160889D0 (da) Mikroboelgeovn
IT8922436A0 (it) Testata tattica
DK378689D0 (da) Quinazolinderivater
KR890021349U (ko) 오븐장치
FI910994A (fi) Mast foer segelfartyg
KR900006273U (ko) 오븐
KR900006272U (ko) 오븐
KR900001013U (ko) 전자레인지
KR920002942U (ko) 전자 레인지
SE8800751D0 (sv) Hoj- och senkbar badplatta
SE8800044D0 (sv) Hoj- och senkbar badplatta

Legal Events

Date Code Title Description
YP Annual fee paid